BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Y, Xu X, Ouyang Y, He C, Li N, Xie C, Peng C, Zhu Z, Shu X, Xie Y, Lu N, Zhu Y. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication. Front Cell Infect Microbiol 2022;12:881968. [DOI: 10.3389/fcimb.2022.881968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu Y, Xu X, Ouyang YB, He C, Li NS, Xie C, Peng C, Zhu ZH, Xie Y, Shu X, Lu NH, Zhu Y. Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter 2022;:e12923. [PMID: 36036087 DOI: 10.1111/hel.12923] [Reference Citation Analysis]
2 Xu W, Xu L, Xu C. Relationship between Helicobacter pylori infection and gastrointestinal microecology. Front Cell Infect Microbiol 2022;12:938608. [DOI: 10.3389/fcimb.2022.938608] [Reference Citation Analysis]
3 Hu Y, Lu NH. Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy. Aliment Pharmacol Ther 2022;56:752-3. [PMID: 35879899 DOI: 10.1111/apt.17114] [Reference Citation Analysis]